Status:
COMPLETED
Effectiveness of VistaO2 Device in Screening of Sleep Apnea/Hypopnea Syndrome
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Collaborating Sponsors:
Novacor
Conditions:
Sleep Apnea Syndromes
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The high prevalence (9% in men and 4% in women) of sleep apnea / hypopnea syndrome (SAHS) in adults is now well documented as well as its cardiovascular repercussions. Previous studies showed a conclu...
Detailed Description
In this perspective, the development of a product screening sleep related breathing disorders for physicians, cardiologists, internists (not specialized sleep experts) would fill this need. It allows ...
Eligibility Criteria
Inclusion
- sleep apnea hypopnea syndrome suspicion
- written consent
Exclusion
- pacemaker
- diabetes
- atrial fibrillation
- electrode allergy
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT01135303
Start Date
February 1 2009
End Date
January 1 2011
Last Update
July 21 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital TENON - APHP
Paris, France, 75000
2
CHU de Saint-Etienne
Saint-Etienne, France, 42055